Frigola J, Vañó D, Torrens A, Gómez-Gomar A, Ortega E, García-Granda S
Department of Medicinal Chemistry, Laboratorios Dr. Esteve, Barcelona, Spain.
J Med Chem. 1995 Mar 31;38(7):1203-15. doi: 10.1021/jm00007a017.
A series of stereochemically pure 7-(3-amino-2-methyl-1-azetidinyl)-1,4- dihydro-6-fluoro-4-oxoquinoline- and -1,8-naphthyridine-3-carboxylic acids, with varied substituents at the 1-, 5-, and 8-positions, was prepared to determine the effects of chirality on potency and in vivo efficacy relative to the racemic mixtures (for part 2, see: J. Med. Chem. 1994, 37, 4195-4210). A series of chiral 9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(substituted-1- azetidinyl)-7H-pyrido[1,2,3- de]-1,4-benzoxazine-6-carboxylic acids was synthesized to study the effect of the azetidine moiety on tricyclic quinolone antibacterial agents. A series of amino acid prodrugs of chiral naphthyridines 24a and 24b and quinolone 33a (cetefloxacin) was prepared and evaluated for antibacterial activity, solubility, and pharmacokinetic behavior. The absolute configuration of the new azetidinylquinolones was established by X-ray analysis of one of the diastereomeric salts of the resolved azetidinols (15) and of compound 25a (E-4767), which showed the best in vitro and in vivo overall profile. Structure-activity relationship studies indicated that the absolute stereochemistry at the asymmetric centers of both the azetidine and the oxazine rings was critical to increase in vitro activity and oral efficacy. The 3S configuration in the pyridobenzoxazine series and the (2S,3R) configuration of the 3-amino-2-methylazetidine moiety for all new compounds conferred the best antibacterial activity.
制备了一系列在1-、5-和8-位具有不同取代基的立体化学纯的7-(3-氨基-2-甲基-1-氮杂环丁烷基)-1,4-二氢-6-氟-4-氧代喹啉-3-羧酸和-1,8-萘啶-3-羧酸,以确定手性对相对于外消旋混合物的效力和体内疗效的影响(关于第2部分,见:《药物化学杂志》1994年,37卷,4195 - 4210页)。合成了一系列手性9-氟-2,3-二氢-3-甲基-7-氧代-10-(取代-1-氮杂环丁烷基)-7H-吡啶并[1,2,3-de]-1,4-苯并恶嗪-6-羧酸,以研究氮杂环丁烷部分对三环喹诺酮类抗菌剂的影响。制备了一系列手性萘啶24a和24b以及喹诺酮33a(西替沙星)的氨基酸前药,并对其抗菌活性、溶解度和药代动力学行为进行了评估。通过对拆分得到的氮杂环丁醇(15)的非对映体盐之一以及化合物25a(E-4767)进行X射线分析,确定了新的氮杂环丁烷基喹诺酮的绝对构型,该化合物在体外和体内的总体表现最佳。构效关系研究表明,氮杂环丁烷环和恶嗪环的不对称中心的绝对立体化学对于提高体外活性和口服疗效至关重要。吡啶并苯并恶嗪系列中的3S构型以及所有新化合物中3-氨基-2-甲基氮杂环丁烷部分的(2S,3R)构型赋予了最佳抗菌活性。